Nivolumab plus ipilimumab in non-small-cell lung cancer - The authors' reply Research Letter

  

Authors:	Hellmann, M. D.; Ramalingam, S. S.
Title:	Nivolumab plus ipilimumab in non-small-cell lung cancer - The authors' reply
Keywords:	antineoplastic agent; ipilimumab; antineoplastic combined chemotherapy protocols; carcinoma, non-small-cell lung; lung neoplasms; lung tumor; non small cell lung cancer; nivolumab; humans; human
Journal Title:	New England Journal of Medicine
Volume:	382
Issue:	9
ISSN:	0028-4793
Publisher:	Massachusetts Medical Society
Date Published:	2020-02-27
Start Page:	875
Language:	English
DOI:	10.1056/NEJMc1916859
PUBMED:	32101674
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080138009&doi=10.1056%2fNEJMc1916859&partnerID=40&md5=f93a2d410f00a3f31c75020e25fe0e02
Notes:	Letter -- Export Date: 1 April 2020 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/163438